End-to-end cell therapy automation

The present disclosure provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, utilizing a fully-enclosed cell engineering system.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	O'CONNOR Joseph, SHI Yaling, SIEHOFF Ann, MCAFEE Erika, BANDAPALLE Samatha, PURPURA Kelly, GLEISSNER Timo, SMITH Timothy, ABRAHAM Eytan, TRAINOR Nuala
Format:	Patent
Sprache:	eng ; heb
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure provides an automated method of producing genetically modified immune cells, including chimeric antigen receptor T (CAR T) cells, utilizing a fully-enclosed cell engineering system.